Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
A smaller body burns less energy at rest, during activity, and even during digestion
Both NNC0090-2746 (107) and tirzepatide (63) delivered clinically meaningful improvements in glycemic control and body weight reduction in their phase 1 trials
If the color appears uneven, gently invert the vial two or three times
The mean follow-up on-treatment was 181 days (median 155 days, IQR 71 to 290 days) for tirzepatide initiators and 174 days (median 148 days, IQR 82 to 254 days) for semaglutide initiators
US$ 24.02
US$ 25.08
US$ 23.34
US$ 21.36
US$ 24.30
